Regulus Therapeutics Inc.

RGLSDelisted Jun 25, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001505512

SEC filings (opens in a new tab)

Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding Regulus Therapeutics Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of RGLS: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	25	26	+1
Shares	10.9M	11.1M	+211.9K (+1.9%)
Value	$15.0M	$14.2M	−$783.1K (−5.2%)

New holders (3)

Institutions that held Regulus Therapeutics Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to RGLS in Q4 2023
Institution	Shares	Value	% of portfolio
Exome Asset Management LLC	178,404	$228.4K	0.23%
Citigroup Inc	2,123	$2.72K	0.00%
Bank of America Corp	11	$14	0.00%

Sold out (2)

Institutions that held Regulus Therapeutics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of RGLS in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Virtu Financial LLC	25,921	$36.0K
Advisor Group Holdings, Inc.	50	$68